Home

News

Teva v Novartis [2022] EWHC 2779 (Ch)19 October 2022Justin Turner KC represented Claimants (“Teva”) seeking an Arrow declaration in relation to fingolimod to treat relapsing-remitting multiple sclerosis at a particular dosage in order to clear out of the way a patent belonging to the Defendant (“Novartis”). After the proceedings commenced but before trial, Novartis withdrew the UK designation of its European patent. Bacon […]
Legal 500 UK Bar Awards 20227 October 2022We are very pleased to announce that Isabel Jamal has won Intellectual Property Junior of the Year at the Legal 500 UK 2022 Bar Awards.  Isabel was a previous recipient of this award in 2019. Chambers was nominated in the Media and the Arts Set of the Year and Intellectual Property Set of the Year […]
Welcome to Our New Pupil – Hadi Godazgar23 September 20228 New Square is very pleased to welcome its new pupil Hadi Godazgar, who will commence his pupillage on 3rd October.
John Lobb Ltd v John Lobb SAS [2022] EWHC 2306 (Ch)8 September 2022Jaani Riordan (led by Huw Davies KC of Essex Court Chambers) appeared for the Defendant/Appellant (“JLSA”), a wholly owned subsidiary of Hermès, in its successful appeal seeking summary dismissal of a claim brought by an English company (“JLL”).  JLL had sought to set aside a 2008 agreement between JLL and JLSA on the basis that […]
IBM UK Ltd v LzLabs GmbH & Ors [2022] EWHC 2094 (TCC)5 August 2022Jaani Riordan appeared as junior counsel in an application for an interim antisuit injunction to restrain the Claimant (“IBM UK”) and its US parent company (“IBM Corp”) from continuing parallel proceedings in Texas and joining IBM Corp as a party to the proceedings in England and Wales.  IBM Corp applied to set aside service under […]
Shenzhen Carku Technology Co v The Noco Company [2022] EWHC 2034 (Pat)4 August 2022James Abrahams QC appeared as lead counsel for the Defendant (“NOCO”) in proceedings brought by the Claimant (“Carku”) to revoke NOCO’s patent for lack of novelty and inventive step.  Carku brought a further claim for damages, alleging NOCO had made groundless threats to Amazon through its UK complaints procedure in relation to Carku’s listed products.  […]
Sandoz & Anr v Bristol-Myers Squibb & Ors [2022] EWHC 1831 (Pat)15 July 2022Andrew Lykiardopoulos QC appeared for Sandoz and Justin Turner QC appeared for Teva  in proceedings to invalidate 4 patents owned by Bristol-Myers Squibb (“BMS”) and Pfizer, both of whom counterclaimed that the generic products which Sandoz and Teva intended to launch on the UK market would infringe. The patents related to a formulation of apixaban […]
Congratulations to Joshua Marshall1 July 2022Chambers is delighted to announce that Joshua Marshall has accepted an offer of tenancy at 8 New Square and will begin practice as a member of chambers in October 2022. Joshua joins chambers after a successful career as an IP solicitor where he was ranked as a “Rising Star” by Legal 500 and Managing IP.
Neurim Pharmaceuticals (1991) Ltd & Anr v Teva UK Ltd [2022] EWHC 1641 (Pat)29 June 2022Charlotte May QC and Henry Ward successfully appeared for the defendant (“Teva”) in a second application brought by the claimants (“Neurim”) for interim injunctive relief, the first application (also successfully defended by Charlotte May QC) having been rejected by Mellor J on 14 April 2022.  The underlying claim related to infringement of Neurim’s patent for […]
Alcon Research v Pharmathen [2022] EWCA Civ 84528 June 2022Lindsay Lane KC and William Duncan appeared for the second defendant (“Aspire”) in an appeal of the judgment of Meade J finding that a patent for the use of fluprostenol isopropyl ester (“FIE”), a prostaglandin F2α (“PGF2α”) analogue, also known as travoprost, for the treatment of glaucoma and ocular hypertension was valid and infringed.  The […]